2026-01-28 - Analysis Report
**Morgan Stanley Report**
==========================

**Company Overview**
-------------------

Morgan Stanley is a multinational investment bank and financial services company.

**Return Rate Comparison**
-------------------------

### Cumulative Return
- MS Review Stock (MS): 283.80%
- S&P 500 (VOO): 128.51%
- Divergence (max: 174.40, min: -20.40, current: 154.60, relative divergence: 89.80%)

The cumulative return of Morgan Stanley is significantly higher than that of the S&P 500. The divergence is 154.60, indicating a substantial difference in performance.

### Annual Performance
| Year        | CAGR | MDD  | Alpha | Beta | Cap(B) |
|-------------|------|------|-------|------|--------|
| 2016-2018   | 6.0% | 21.5% | -2.0% | 1.6  | 63.0B  |
| 2017-2019   | -14.0% | 21.5% | -39.0% | 1.3  | 81.2B  |
| 2018-2020   | 14.0% | 49.7% | -10.0% | 1.4  | 108.9B |
| 2019-2021   | 123.0% | 49.7% | 59.0% | 1.4  | 156.0B |
| 2020-2022   | 55.0% | 49.7% | 51.0% | 1.3  | 135.1B |
| 2021-2023   | 32.0% | 30.4% | 14.0% | 1.1  | 148.2B |
| 2022-2024   | 27.0% | 30.4% | -3.0% | 1.1  | 199.8B |
| 2023-2025   | 148.0% | 28.7% | 73.0% | 1.3  | 282.1B |

The company's annual performance shows significant fluctuations, with a high CAGR of 123.0% in 2019-2021.

**Recent Stock Price Fluctuations**
----------------------------------

### Moving Averages
- Close: $182.66
- 5-day SMA: $181.98
- 20-day SMA: $183.55
- 60-day SMA: $174.54

The stock price has been relatively stable, with the close price fluctuating around the 5-day and 20-day SMA.

**Market Risk Indicator and Indicators**
---------------------------------------

### Market Risk Indicator (MRI)
- MRI: 0.70 (Low Investment)

The MRI indicates a relatively low level of investment risk.

### RSI, PPO, and Hybrid Signal
- RSI: 43.56
- PPO: -0.52
- Hybrid Signal: Buy (Cash 0%)
- Risk Level: Medium (MRI 0.70)

The RSI and PPO indicators suggest a neutral to buy signal. The hybrid signal also suggests a buy signal, with a moderate risk level.

### Expected Return and Excess Return
- Expected Return: 13.10%
- Expected excess return compared to S&P 500 if invested long-term: 13.10%

The expected return is relatively high, indicating potential for long-term growth.

**Recent News and Significant Events**
--------------------------------------

### News Articles
- [2026-01-27] Nvidia Stock Gains. Microsoft’s New AI Chip Can’t Keep It Down. - Barron's
- [2026-01-27] Jed Finn to Speak at the UBS Financial Services Conference - Stock Titan
- [2026-01-27] Richtech Robotics stock soars on Microsoft AI collaboration - Investing.com
- [2026-01-23] Microsoft (MSFT) Stock Is Up, What You Need To Know - Yahoo Finance
- [2026-01-27] Richtech Robotics Stock Jumps 43% — What’s The Connection With Microsoft? - Stocktwits
- [2026-01-27] Richtech Robotics Stock Surges On Microsoft AI Partnership - Benzinga

The recent news articles indicate significant events and partnerships that may impact the company's performance.

**Analyst Opinions**
--------------------

### Analyst Consensus
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.40 (~Buy)
- Opinions: 21
- Target Price (avg/high/low): 194.19 / 221.00 / 148.00

The analyst consensus suggests a buy signal, with a target price range of $194.19 to $221.00.

**Recent Earnings Analysis**
---------------------------

### Quarterly Earnings
| Date       | EPS | Revenue |
|------------|-----|---------|
| 2025-10-29 | 3.73 | 77.67 B |
| 2025-04-30 | 3.47 | 70.07 B |
| 2025-01-29 | 3.24 | 69.63 B |
| 2024-10-30 | 3.32 | 65.58 B |

The company's quarterly earnings have been relatively stable, with a high revenue of $77.67 B in 2025-10-29.

**Financial Information**
-----------------------

The financial information table is not available for MS.

**Comprehensive Analysis**
-------------------------

### Summary
Morgan Stanley's cumulative return is significantly higher than that of the S&P 500, with a relatively high expected return of 13.10%. The company's annual performance shows significant fluctuations, with a high CAGR of 123.0% in 2019-2021. The market risk indicator suggests a relatively low level of investment risk. The recent news articles indicate significant events and partnerships that may impact the company's performance. The analyst consensus suggests a buy signal, with a target price range of $194.19 to $221.00.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.